Key result
Renal denervation is linked to a ~29 mmHg drop in 30-day systolic blood pressure.
Why the study?
Only 35% of hypertensive patients achieve controlled blood pressure levels, and this study evaluated the 30-day blood pressure response and safety of renal sympathetic denervation in patients with resistant systemic hypertension.
Observational (n=20)
Yes
Answers are grounded in this paper and cite their sources.
May support short-term RSD evaluation in resistant hypertension; leaves open randomized confirmation before practice change.
Systemic arterial hypertension affects over 1.2 million people worldwide. Only 35% of hypertensive patients have controlled blood pressure levels. Renal sympathetic denervation (RSD) has shown to significantly decrease blood pressure levels in patients with resistant systemic hypertension. Prospective, single arm, observational, multicenter study including consecutive patients undergoing RSD. The primary endpoint was to assess systolic blood pressure levels at the 30-day follow-up. The secondary endpoint was to determine the presence of procedure-related adverse events. The first 20 patients undergoing RSD were included. The average blood pressure prior the procedure was 171.6/93.2 ± 15.5/ 11.3 mmHg, with the use of 4.1 ± 1.5 antihypertensive drugs per patient. Success rate was 95%, and 11.1 ± 1.9 ablations were performed per patient. A systolic blood pressure decrease of 29 ± 21 mmHg (P = 0.009) was observed 30 days after the procedure. There were no procedure-related complications. Catheter-based RSD in daily clinical practice patients significantly decreased blood pressure levels. In our experience, RSD proved to be feasible and safe. Denervação Simpática Renal para o Controle da Hipertensão Arterial Resistente A hipertensão arterial sistêmica afeta mais de 1,2 milhão de pessoas no mundo. Apenas 35% dos pacientes hiper-tensos têm valores de pressão arterial controlados. Recentemente a denervação simpática renal (DSR) tem demonstrado diminuir significativamente os valores de pressão arterial nos pacientes com hipertensão arterial sistêmica resistente. Estudo prospectivo, de braço único, observacional, multicêntrico, in-cluindo pacientes consecutivos submetidos a DSR. O objetivo primário foi avaliar os níveis da pressão arterial sistólica aos 30 dias de seguimento. O objetivo secundário foi determinar a ocorrência de qualquer evento adverso relacionado com o procedimento. Foram incluídos os primeiros 20 pacientes submetidos a DSR. A média de pressão arterial antes do procedimento foi de 171,6/93,2 ± 15,5/11,3 mmHg, com média de uso de 4,1 ± 1,5 fármacos anti-hipertensivos por paciente. A taxa de sucesso foi de 95%, tendo sido aplicadas 11,1 ± 1,9 ablações por paciente. Foi observada diminuição média de 29 ± 21 mmHg (P = 0,009) na pressão arterial sistólica 30 dias após o procedimento. Não houve complicação associada ao procedimento. A DSR por cateter em pacientes da prática clínica diária diminuiu significativamente os valores de pressão arterial. Em nossa experiência, a DSR demonstrou ser factível e segura.
No takes yet. Share an insight, caveat, or question.
Collet et al. (2013) conducted an observational in Resistant systemic hypertension (n=20). Catheter-based renal sympathetic denervation (RSD) vs. Baseline pre-procedure blood pressure (single-arm) was evaluated on Systolic blood pressure levels at the 30-day follow-up (MD -29 ± 21 mmHg, p=0.009). Catheter-based renal sympathetic denervation decreased systolic blood pressure by 29 ± 21 mmHg at 30 days with no procedure-related complications.
Synapse has enriched 10 related papers. Consider them for comparative context: